Cite Filings / SABS / 0001104659-21-127418
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

SAB Biotherapeutics, Inc. · Filed 2021-10-19 · Acc 0001104659-21-127418

Documents 1

  • SC 13G Amended Statement of Ownership , tm2130492d1_sc13g.htm

Around this filing

  • 2023-10-16 SC 13G Amended Statement of Ownership
  • 2021-10-22 3 Initial Statement of Ownership
  • 2021-10-22 3 Initial Statement of Ownership
  • 2021-10-22 3 Initial Statement of Ownership
  • 2021-10-21 8-K Shareholder vote results
  • 2021-10-19 SC 13G Amended Statement of Ownership
  • 2021-02-24 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Vivo Opportunity Fund Holdings, L.P. 9.99%
  2. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 7.94%
  3. 2026-11-16 SCHEDULE 13G/A · Woodline Partners LP 5.7%
Loading tm2130492d1_sc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…